Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K. Nouso K, et al. Among authors: hagihara h. J Gastroenterol Hepatol. 2011 Jul;26(7):1195-200. doi: 10.1111/j.1440-1746.2011.06720.x. J Gastroenterol Hepatol. 2011. PMID: 21410750
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.
Takeuchi Y, Ikeda F, Moritou Y, Hagihara H, Yasunaka T, Kuwaki K, Miyake Y, Ohnishi H, Nakamura S, Shiraha H, Takaki A, Iwasaki Y, Nouso K, Yamamoto K. Takeuchi Y, et al. Among authors: hagihara h. J Gastroenterol. 2013 Mar;48(3):405-12. doi: 10.1007/s00535-012-0647-3. Epub 2012 Aug 7. J Gastroenterol. 2013. PMID: 22869157 Free article.
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
Nouso K, Amano M, Ito YM, Miyahara K, Morimoto Y, Kato H, Tsutsumi K, Tomoda T, Yamamoto N, Nakamura S, Kobayashi S, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Nakahara T, Nishimura S, Yamamoto K. Nouso K, et al. Among authors: hagihara h. J Gastroenterol. 2013 Oct;48(10):1171-9. doi: 10.1007/s00535-012-0732-7. Epub 2013 Jan 11. J Gastroenterol. 2013. PMID: 23307043
Prognotic impact of serum follistatin in patients with hepatocellular carcinoma.
Tomoda T, Nouso K, Miyahara K, Kobayashi S, Kinugasa H, Toyosawa J, Hagihara H, Kuwaki K, Onishi H, Nakamura S, Ikeda F, Miyake Y, Shiraha H, Takaki A, Yamamoto K. Tomoda T, et al. Among authors: hagihara h. J Gastroenterol Hepatol. 2013 Aug;28(8):1391-6. doi: 10.1111/jgh.12167. J Gastroenterol Hepatol. 2013. PMID: 23432377
Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.
Adachi T, Nouso K, Miyahara K, Oyama A, Wada N, Dohi C, Takeuchi Y, Yasunaka T, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Takabatake H, Fujioka SI, Kobashi H, Takuma Y, Iwadou S, Uematsu S, Takaguchi K, Hagihara H, Okada H; Okayama Liver Cancer Group. Adachi T, et al. Among authors: hagihara h. J Gastroenterol Hepatol. 2019 Jun;34(6):1081-1087. doi: 10.1111/jgh.14535. Epub 2018 Dec 10. J Gastroenterol Hepatol. 2019. PMID: 30402928
Prognostic model for hepatocellular carcinoma with time-dependent factors.
Kuwaki K, Nouso K, Kobayashi Y, Nakamura S, Ito YM, Iwadou S, Hagihara H, Yasunaka T, Toshimori J, Miyatake H, Miyoshi K, Onishi H, Miyake Y, Shoji B, Takaki A, Shiraha H, Iwasaki Y, Kobashi H, Yamamoto K. Kuwaki K, et al. Among authors: hagihara h. Acta Med Okayama. 2011 Feb;65(1):11-9. doi: 10.18926/AMO/43825. Acta Med Okayama. 2011. PMID: 21339791 Free article.
143 results